Study results using a quality-by-design method, risk-based monitoring, and real-time direct data entry.
Sergio Dalla Nora
Advertisement
(Sergio.DallaNora@ferring.com) Associate Director of Clinical Research Ferring Canada
Articles by Sergio Dalla Nora
Advertisement
Latest Updated Articles
Three-Pronged Approach to Optimizing Trial MonitoringPublished: June 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
3
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
4
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
